Left atrial appendage occlusion is an evolving technology with demonstrable benefits of stroke prophylaxis in patients with atrial fibrillation unsuitable for anticoagulation. This has resulted in the development of a plethora of transcatheter devices to achieve epicardial exclusion and endocardial occlusion. In this review, the authors summarize the differences in technique, target patient population, outcomes, and complication profiles of endocardial and epicardial techniques.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ccep.2019.11.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Trials and tribulations of cell therapy for heart failure: an update on ongoing trials.
Nat Rev Cardiol
November 2024
Department of Cardiovascular Surgery, Hôpital Européen Georges Pompidou, Université de Paris, PARCC, INSERM, Paris, France.
Article Synopsis
Open-chest cardiac ultrasound-mediated imaging with a vacuum coupler.
Med Phys
November 2024
Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Background: A fundamental obstacle for the preclinical development of ultrasound-(US) mediated cardiac imaging remains cardiac motion, which limits interframe correlation during extended acquisition periods.
Purpose: To address this need, we present the design and implementation of a 3D-printed vacuum coupler that stabilizes a US transducer on the epicardial surface of the heart for feasibility assessment and development of advanced, cardiac, US-mediated imaging approaches.
Methods: The vacuum coupler was 3D printed with biocompatible resins and secured with a standard intraoperative suction aspirator.
Evaluation of Intravenous Versus Intracoronary Adenosine in Coronary Reactivity Testing.
Am J Cardiol
January 2025
Department of Internal Medicine, Baylor Scott and White, Temple, Texas; Division of Cardiology, Baylor Scott and White, Temple, Texas. Electronic address:
Coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) obtained through coronary bolus thermodilution are used to assess and treat patients with angina and no obstructive coronary artery disease. Previous studies demonstrate comparable results assessing epicardial ischemia by fractional flow reserve using intravenous (IV) or intracoronary (IC) adenosine. It is unknown if there is a similarity between IC and IV hyperemia with adenosine when performing coronary reactivity testing (CRT).
View Article and Find Full Text PDFAortic versus distal pressure for derivation of hyperaemic microvascular resistance: From the ILIAS registry.
Int J Cardiol
January 2025
Department of Cardiology, Amsterdam UMC - Location AMC, Amsterdam, the Netherlands.
Article Synopsis
- In patients with angina but no major coronary blockages (ANOCA), researchers investigated whether measuring hyperaemic microvascular resistance (HMR) using aortic pressure (Pa) is as effective as using distal pressure (Pd).
- Analysis of data from the ILIAS registry showed a strong correlation between HMR calculated with Pa and Pd, especially in patients with functional epicardial lesions rated as non-severe (FFR >0.80).
- The study concluded that while HMR can be accurately determined using aortic pressure in patients with non-severe lesions, significant discrepancies occur when measuring in patients with more severe lesions (FFR <0.80).
Lipomatous hypertrophy of the interatrial septum: a distinct adipose tissue type in COPD?
ERJ Open Res
September 2024
Department of Radiology, Innsbruck Medical University, Innsbruck, Austria.
Objective: Lipomatous hypertrophy of the interatrial septum (LHIS) is a distinct section of epicardial adipose tissue. However, its association with COPD is poorly documented.
Methods: Patients undergoing coronary computed tomography angiography (CTA) for clinical indications were recruited retrospectively and screened for LHIS and COPD.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!